CNSX:TRULPharmaceuticals
Trulieve’s 2025 Loss Narrows On Flat Sales Might Change The Case For Investing In Trulieve Cannabis (CNSX:TRUL)
Trulieve Cannabis Corp. has reported past full-year 2025 results, with sales of US$1,181.18 million and a net loss of US$116.38 million, narrowing its loss per share from US$0.79 to US$0.58 year over year.
The combination of essentially flat annual sales and a smaller net loss suggests progress on cost control and efficiency, even as overall revenue stayed steady.
Next, we’ll examine how Trulieve’s reduced net loss, alongside previously expected regulatory and growth drivers, may influence...